For patients with coronary heart disease, drugs such as nitroglycerin, coronary interventional stent placement, and coronary artery bypass surgery may not be unfamiliar, and they are widely used in the treatment of heart disease. However, some patients still have manifestations of myocardial ischemia after the above treatments, what should be done?

● Have you heard of EECP?

EECP is a safe, non-invasive, and side-effect physical therapy. It is also a passive exercise. It has been listed as the fourth method for the treatment of coronary heart disease in addition to drugs, stents, and bypasses. It is a green heart rehabilitation therapy advocated by the country. Also known as "biological bypass technique".

Recently, the People's Hospital of Pingyi County has successfully introduced two enhanced external counterpulsation devices, giving Pingyi County and surrounding areas more options for the treatment of patients with cardiovascular and cerebrovascular diseases. After nearly a month of use, more than 40 patients have benefited, and the symptoms of palpitation, chest tightness, chest pain, shoulder and back pain have been improved, and the stability of sleep, fatigue, dizziness, tinnitus, ischemic premature contractions, and hypertension has been improved. Played an unexpected effect.

Mr. Liu, 71 years old, is one of the first beneficiaries.

Old man Liu underwent coronary angiography due to pain in the precordial area two years ago and found multivessel disease in the coronary artery. Later, he underwent coronary artery bypass surgery. After the operation, he still had chest tightness, fatigue, and pain in the precordial area after fatigue. Treatment, the above symptoms still exist. This visit to Pingyi County People’s Hospital coincided with the introduction of external counterpulsation equipment. After 5 days of external counterpulsation treatment, the patient's discomfort symptoms improved significantly, chest pain no longer appeared, fatigue and chest tightness were significantly improved, and there were basically no symptoms after 10 days of treatment , Happily discharged from hospital.

● What is EECP machine?

EECP machine is to wrap the lower limbs and buttocks of the human body with special airbag tubes. The electronic control system detects the R wave of the human electrocardiogram as the trigger signal. In the early diastole, the airbags of each segment are sequentially inflated and compressed from the far and the near , To drive the blood of the lower extremities and buttocks to the aorta, thereby improving the blood supply of the heart, brain, kidney and five sense organs.

● What does EECP therapy do?

1. Cardiovascular disease:

Angina pectoris, myocardial ischemia, myocardial infarction, heart failure, coronary artery bypass surgery, coronary artery stent implantation, patients with severe coronary artery disease who are unable or unwilling to undergo surgical bypass or coronary stent implantation, or caused by insufficient blood supply to the heart Arrhythmia, coronary heart disease and diabetes.

2. Cerebrovascular disease:

Cerebral arteriosclerosis, cerebral thrombosis, lacunar cerebral infarction, transient ischemic attack, vertebra-basal artery insufficiency, senile and cerebrovascular cerebral dementia, Parkinson, vertigo syndrome, sequelae of cerebrovascular accident , Children with cerebral palsy, sequelae of cerebrovascular accident.

3. Diseases of the five sense organs:

Fundus artery embolism, central serous retina, choroidal disease, optic nerve atrophy, sudden deafness.

4. Peripheral vascular disease:

Arteriosclerotic limb vascular stenosis, thromboangiitis obliterans, peripheral circulatory disorders.

5. Other diseases:

Ischemic kidney disease, hepatitis, mental fatigue, insomnia, neurasthenia, memory loss, hypertension, diabetes, chronic pelvic inflammatory disease, sports fatigue, sub-health patients to eliminate fatigue and health care.

What diseases are not suitable for EECP?

Moderate to severe aortic regurgitation, congenital heart disease, right heart failure, pulmonary heart disease, pulmonary embolism; systemic or local hemorrhagic diseases, such as early cerebral hemorrhage, dissecting aneurysm, respiratory tract hemorrhage, gastrointestinal hemorrhage, urinary system hemorrhage , Thrombocytopenic purpura; pregnancy; lower limb venous thrombosis, phlebitis or infectious diseases; high blood pressure ≥170/100mmhg.